Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Annals of the Rheumatic Diseases
|
June 15, 2022
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration
Kim Lauper, Michele Iudici, Denis Mongin, et al.
Arthritis Care & Research
|
June 26, 2024
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries
Louise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, et al.
BMC Rheumatology
|
July 2, 2025
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study
Stylianos Georgiadis, Daniela Di Giuseppe, Almut Scherer, et al.
RMD Open
|
February 20, 2025
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis
Stylianos Georgiadis, Marion Pons, Simon Rasmussen, et al.
BMC Medical Research Methodology
|
February 28, 2025
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased
Christos Polysopoulos, Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, et al.
The Journal of Rheumatology
|
January 15, 2024
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care
Lykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, et al.
EULAR Rheumatology Open
|
June 29, 2026
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients
Zohra Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, et al.
Rheumatology (Oxford, England)
|
March 24, 2022
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
Michael Nissen, Bénédicte Delcoigne, Daniela Di Giuseppe, et al.
Rheumatology (Oxford, England)
|
June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
Louise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
Rheumatology (Oxford, England)
|
January 22, 2020
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis
Brigitte Michelsen, Lykke Midtbøll Ørnbjerg, Tore K Kvien, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Annals of the Rheumatic Diseases
|
June 15, 2022
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration
Kim Lauper, Michele Iudici, Denis Mongin, et al.
Arthritis Care & Research
|
June 26, 2024
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries
Louise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, et al.
BMC Rheumatology
|
July 2, 2025
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study
Stylianos Georgiadis, Daniela Di Giuseppe, Almut Scherer, et al.
RMD Open
|
February 20, 2025
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis
Stylianos Georgiadis, Marion Pons, Simon Rasmussen, et al.
BMC Medical Research Methodology
|
February 28, 2025
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased
Christos Polysopoulos, Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, et al.
The Journal of Rheumatology
|
January 15, 2024
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care
Lykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, et al.
EULAR Rheumatology Open
|
June 29, 2026
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients
Zohra Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, et al.
Rheumatology (Oxford, England)
|
March 24, 2022
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
Michael Nissen, Bénédicte Delcoigne, Daniela Di Giuseppe, et al.
Rheumatology (Oxford, England)
|
June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
Louise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
Rheumatology (Oxford, England)
|
January 22, 2020
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis
Brigitte Michelsen, Lykke Midtbøll Ørnbjerg, Tore K Kvien, et al.
Page
of 7